CompaniesByCap
RYTM
Rhythm Pharmaceuticals Inc. (RYTM)
NASDAQ · Healthcare

Rhythm Pharmaceuticals Inc. Income Statement 2016–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenues
Revenue189.8M130.1M77.4M23.6M3.2M00000
Gross Profit170.3M116.8M68.1M21.5M2.6M
Profitability
Operating Income-192.0M-265.5M-184.4M-179.2M-170.1M-136.6M-146.0M-78.4M-32.4M-25.9M
EBITDA-191.5M-264.8M-183.5M-178.3M-169.2M-135.9M-145.2M-78.0M-32.2M-25.8M
Net Income-196.5M-260.6M-184.7M-181.1M-69.6M-134.0M-140.7M-74.1M-33.7M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)65M61M58M52M50M44M36M34M27M10M

Rhythm Pharmaceuticals Inc. Income Statement — FAQ

Rhythm Pharmaceuticals Inc. (RYTM) income statement over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see RYTM's income statement history?

The chart and table above show Rhythm Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.